Migril 2 mg, 50 mg, 100 mg Tablet.
PDF Leaflet Revision Date: 15 July 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of acute migraine attacks.
Dosage (summary)
Initial dose: 1 tablet; may repeat half to 1 tablet every 30 mins as needed.
Special Populations
- Elderly
- Children
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- CYP3A4 inhibitors
- Beta-blockers
- CNS depressants
Contraindications
- Sensitivity to components
- Vascular disease
- Pregnancy
- Lactation
Common side effects
- Dizziness
- Drowsiness
- Nausea
- Vomiting
Counselling Points
- Avoid alcohol
- Do not exceed recommended dose
- Lie down in a dark room after taking
Serious warnings
- Risk of ergotism
- Dependence with habitual use
Important Disclaimer
The Migril 2 mg, 50 mg, 100 mg Tablet. professional information leaflet below is the property of Inova Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
